Provided by Tiger Trade Technology Pte. Ltd.

Global X Aging Population ETF

36.59
-0.0890-0.24%
Post-market: 36.660.0706+0.19%19:30 EDT
Volume:8K
Turnover:304.42K
Market Cap:90.37M
PE:- -
High:36.81
Open:36.81
Low:36.53
Close:36.68
52wk High:39.48
52wk Low:32.44
Shares:2.47M
Float Shares:2.47M
Volume Ratio:1.27
T/O Rate:0.34%
Dividend:0.33
Dividend Rate:0.89%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

GeoVax Updates Nasdaq Listing Amid Ongoing Clinical Progress

TIPRANKS
·
Yesterday

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Insight Guru Flags Valuation Flip as Merck Trades at 52.2x Operating Profit vs Lilly 25.3x

Reuters
·
Yesterday

AbbVie Declares Quarterly Cash Dividend of $1.73 a Share

Reuters
·
Yesterday

Abbvie - Declares Qtrly Cash Dividend of $1.73 Per Share

THOMSON REUTERS
·
Yesterday

AbbVie’s Eye Implant Study Delivers Fresh Real‑World Clarity for Investors

TIPRANKS
·
Yesterday

Eli Lilly is Maintained at Reduce by HSBC

Dow Jones
·
Sep 10

WELL Health Technologies Corp (WELL) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
Sep 10

Eli Lilly’s GLP-1 Windfall to Fund Push into Women’s Health - Bloomberg News

Reuters
·
Sep 10

AbbVie Says Atogepant Met Primary, Secondary Endpoints in Phase 3 Menstrual Migraine Study

MT Newswires Live
·
Sep 10

U.K. Competition Watchdog Accepts Welltower's Concessions in Care Home Deal

Dow Jones
·
Sep 10

AbbVie’s atogepant shows positive Phase 3 results in menstrual migraine

TIPRANKS
·
Sep 10

Abbvie - Atogepant Safety Results Consistent with Known Profile; no New Safety Signals

THOMSON REUTERS
·
Sep 10

Abbvie - Atogepant Meets Primary and All Eight Ranked Secondary Endpoints in Phase 3 Luna Study

THOMSON REUTERS
·
Sep 10

Abbvie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine

THOMSON REUTERS
·
Sep 10

Abbvie - Atogepant Shows Significant Improvements Across Multiple Endpoints Versus Placebo

THOMSON REUTERS
·
Sep 10

Welltower Care Home Acquisitions Avoid In-Depth UK CMA Investigation

MT Newswires Live
·
Sep 10

Alerts Incorrectly Tagged to Willis Towers Watson Withdrawn

Reuters
·
Sep 10

Edwards Lifesciences (EW) Gets a Buy from Citi

TIPRANKS
·
Sep 10

UK's Cma Says Acceptance of Undertakings in Lieu of Welltower / Multiple Care Homes Deal

THOMSON REUTERS
·
Sep 10